Immucor BLUD shares have risen more than 8% on Friday in early trade after the company reported better than expected earnings on Thursday after the closing bell.
The company reported EPS of $0.30 versus analysts' consensus of $0.27. Year over year revenues were down 1.2%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in